Breakthrough business models : drug development for rare and neglected diseases and individualized therapies: workshop summary / [edited by] Theresa Wizeman, Sally Robinson, and Robert Giffin ; Forum on Drug Discovery, Development, and Translation, Board on Health Services Policy, Institute of Medicine of the National Academies.
2009
RA401.A3 B74 2009eb
Formats
| Format | |
|---|---|
| BibTeX | |
| MARCXML | |
| TextMARC | |
| MARC | |
| DublinCore | |
| EndNote | |
| NLM | |
| RefWorks | |
| RIS |
Linked e-resources
Details
Title
Breakthrough business models : drug development for rare and neglected diseases and individualized therapies: workshop summary / [edited by] Theresa Wizeman, Sally Robinson, and Robert Giffin ; Forum on Drug Discovery, Development, and Translation, Board on Health Services Policy, Institute of Medicine of the National Academies.
ISBN
9780309120890 (electronic bk.)
0309120896 (electronic bk.)
1282083554
9781282083554
9786612083556
6612083557
0309178169
9780309178167
9780309120883
0309120888
0309120896 (electronic bk.)
1282083554
9781282083554
9786612083556
6612083557
0309178169
9780309178167
9780309120883
0309120888
Imprint
Washington, D.C. : National Academies Press, ©2009.
Language
English
Language Note
English.
Description
1 online resource (xviii, 132 pages)
Call Number
RA401.A3 B74 2009eb
System Control No.
(OCoLC)311565225
Summary
"The Institute of Medicine's Forum on Drug Discovery, Development, and Translation held a public workshop on June 23, 2008, titled "Breakthrough Business Models: Drug Development for Rare and Neglected Diseases and Individualized Therapies." The purpose of the workshop was to explore innovative strategies for orphan drug development."
Bibliography, etc. Note
Includes bibliographical references.
Formatted Contents Note
Introduction and overview
Current model for financing drug development: from concept through approval
The Food and Drug Administration's Orphan Drug Program
Diverse funding models
Strategies for facilitating sharing of research materials and data
Strategies of navigation intellectual property
Strategies for facilitating clinical trials
Summary.
Current model for financing drug development: from concept through approval
The Food and Drug Administration's Orphan Drug Program
Diverse funding models
Strategies for facilitating sharing of research materials and data
Strategies of navigation intellectual property
Strategies for facilitating clinical trials
Summary.
Digital File Characteristics
data file
Source of Description
Print version record.
Added Corporate Author
Series
Online access: NCBI NCBI Bookshelf.
Available in Other Form
Print version: Breakthrough business models. Washington, D.C. : National Academies Press, ©2009
Linked Resources
Record Appears in